Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
J Nutr. 2020 Oct 12;150(10):2772-2788. doi: 10.1093/jn/nxaa212.
Mechanisms linking habitual consumption of coffee and tea to the development of type 2 diabetes and cardiovascular diseases remain unclear.
We leveraged dietary, genetic, and biomarker data collected from the UK Biobank to investigate the role of different varieties of coffee and tea in cardiometabolic health.
We included data from ≤447,794 participants aged 37-73 y in 2006-2010 who provided a blood sample and completed questionnaires regarding sociodemographic factors, medical history, diet, and lifestyle. Multivariable linear regression was used to examine the association between coffee or tea consumption and blood concentrations of glycated hemoglobin, fasting glucose, total cholesterol, HDL cholesterol, LDL cholesterol, fasting triglycerides (TGs), apoA-1, apoB, lipoprotein-a, and C-reactive protein (CRP). Lifestyle and genetic factors affecting caffeine metabolism, responses, or intake were tested for interactions with beverage intake in relation to biomarker concentrations.
Compared with coffee nonconsumers, each additional cup of coffee was significantly associated with higher total cholesterol, HDL-cholesterol, and LDL-cholesterol concentrations and lower TG and CRP concentrations in both men and women (P-trend < 0.002). Higher consumption of espresso coffee (≥2 compared with 0 cups/d) was associated with higher LDL cholesterol in men (β: 0.110 mmol/L; 95% CI: 0.058, 0.163 mmol/L) and women (β: 0.161 mmol/L; 95% CI: 0.088, 0.234 mmol/L), whereas no substantial association was observed for instant coffee. Compared with tea nonconsumers, higher tea consumption was associated with lower total and LDL cholesterol and apoB and higher HDL cholesterol (P-trend < 0.002); these associations were similar for black and green tea. Associations were not modified by genetics.
In the UK Biobank, consumption of certain coffee brews such as espresso had unfavorable associations with blood lipids, whereas consumption of tea had favorable associations. Findings were not modified by genetic variants affecting caffeine metabolism, suggesting a role of noncaffeine constituents of these beverages in cardiometabolic health.
将习惯性摄入咖啡和茶与 2 型糖尿病和心血管疾病的发展联系起来的机制仍不清楚。
我们利用英国生物库收集的饮食、遗传和生物标志物数据,研究不同种类的咖啡和茶在心脏代谢健康中的作用。
我们纳入了 2006-2010 年间年龄在 37-73 岁的≤447794 名参与者的数据,这些参与者提供了血液样本,并完成了关于社会人口因素、病史、饮食和生活方式的问卷调查。多变量线性回归用于检查咖啡或茶的摄入量与糖化血红蛋白、空腹血糖、总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、空腹甘油三酯 (TG)、载脂蛋白 A-1、载脂蛋白 B、脂蛋白-a 和 C 反应蛋白 (CRP) 血浓度之间的关联。测试了影响咖啡因代谢、反应或摄入的生活方式和遗传因素与饮料摄入之间的相互作用,以了解其与生物标志物浓度的关系。
与不喝咖啡的人相比,男性和女性中,每多喝一杯咖啡,总胆固醇、高密度脂蛋白胆固醇和低密度脂蛋白胆固醇浓度显著升高,TG 和 CRP 浓度显著降低(P 趋势<0.002)。与不喝咖啡的人相比,男性(β:0.110mmol/L;95%CI:0.058,0.163mmol/L)和女性(β:0.161mmol/L;95%CI:0.088,0.234mmol/L)中,饮用浓咖啡(≥2 杯/天,而不是 0 杯/天)与 LDL 胆固醇升高有关,而饮用速溶咖啡则没有明显关联。与不喝茶的人相比,饮茶量较高与总胆固醇和 LDL 胆固醇及载脂蛋白 B 降低和高密度脂蛋白胆固醇升高有关(P 趋势<0.002);黑茶和绿茶也有类似的关联。遗传因素没有改变这些关联。
在英国生物库中,某些咖啡品种(如浓咖啡)的消费与血液脂质呈不利关联,而茶的消费与血液脂质呈有利关联。遗传变异对咖啡因代谢的影响并未改变这些发现,这表明这些饮料中非咖啡因成分在心脏代谢健康中的作用。